Recent

% | $
Quotes you view appear here for quick access.

Teva Pharmaceutical Industries Limited Message Board

  • jeremysikessr jeremysikessr May 1, 2013 11:14 AM Flag

    I like AMGN better than TEVA...here is why

     

    NEW AMGN TARGET raised 30% to $130!!!! At GOLDMAN!!!! CONVICTION BUY!!!

    NEW AMGN TARGET raised 30% to $130!!!! At GOLDMAN!!!! CONVICTION BUY!!!

    Amgen upgraded to Conviction Buy from Neutral

    Goldman Sachs has upgraded the company to its Conviction Buy list, with a price target of $130 up from $100, citing a “more favorable combination of catalysts and upside potential.” ”We project that AMGN’s pipeline (key readouts in 1Q14-2015) and own biosimilars (first launch in 2017) will allow it to replace the potential revenue that could be lost to competition and grow its base,” Goldman analyst Terence Flynn said.
    Goldman upgraded Amgen (AMGN) based on valuation and its late-stage pipeline which is highly innovative and has the potential to replace key biologic franchises that are coming off patent.

    Could easily be 107 or better this week

    RESEARCH…..then
    BUY BUY BUY

    Sentiment: Strong Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
TEVA
60.95+1.85(+3.13%)Jul 1 4:04 PMEDT